Recent

% | $
Quotes you view appear here for quick access.

công ty Affymax Message Board

joenobody02 60 posts  |  Last Activity: Jun 24, 2015 6:07 PM Member since: Dec 22, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • joenobody02 by joenobody02 Jun 16, 2015 11:55 AM Flag

    GALE is in big trouble. Both New/Vax and G-301 trails are showing great results. As such it will be a target for takeover --- on the cheap. Here are the problems.
    (1) Very low institutional ownership - Less than 20% are owned by institutions. Even I own more than Goldman Sucks and that tells you in a hostile takeover, no powerful institution will come to the defense of GALE.
    (2) The potential suitor Roche has been found guilty of fixing vitamin price in Europe and was fined half a billion dollars - the biggest ever at the time for price fixing. You think they will pay up to a little nothing of a biotech like GALE ? Here, $5 take it or leave it.
    (3) Management has a checkered past. That was one of the reasons I hesitated when thinking of investing and I jumped in and out several times in the past but am tempted by the G301 data and hence come back in. You don't think the management will sell out the shareholders if Roche offer them a golden parachute ? Think again.
    What then can GALE do to safe guide its shareholder interest ? Plenty if they want to do it. OR, if they are pushed by shareholders to do it.
    (a) They can go on a road show to promote the company to other institutions . They can even go talk to the big institution holders , telling them the danger of a cheap takeover and what the values of GALE is. They can ask the big guys to help. Blackrock holds a lot of shares and they probably can do a lot that the GALE management cannot - like getting more instuitions interested and advise them how to fend off a hostile takeover. e.g. put in a poison pill (e.g. 1:100 shares issue if hostile takeover were to occur ). It s true last quarter there were big increase in institution ownership but it is still not enough and way too low.
    (b) Partner with other big pharmaceutical companies, sort of give them the right to other Neu/Vax or G-301 in exchange for % payment. By leaving not much in house for Roche to benefit from, Roche may decide to partner instead.

  • Reply to

    How can GALE save its own life

    by joenobody02 Jun 16, 2015 11:55 AM
    joenobody02 joenobody02 Jun 16, 2015 1:22 PM Flag

    I think GALE can reach its true value by going out now to negotiate with the pharmaceutical companies . Sell the right to market in Japan to the Japanese. Sell the Chinese marketing right to the Chinese. Leave Europe to Roche. Sell the US right to Merck or Pfizer or JNJ or whatever. I bet the share price will go up incrementally as each right is sold and the incentive for Roche to partner increases. I think we get the top dollar this way compare to selling the whole company to a single entity like Roche . Shareholders, go to quarterly meetings annual meetings etc to make your voice heard (very politely and diplomatically).

  • Reply to

    What?

    by mikesioc May 7, 2015 2:22 AM
    joenobody02 joenobody02 May 7, 2015 3:15 AM Flag

    At this point, a buy out rumour is nothing but mental masturbation.

  • joenobody02 by joenobody02 May 31, 2015 11:34 AM Flag

    for us to ask Yahoo take action against AVI for destroying the board.

  • joenobody02 joenobody02 Jun 22, 2015 1:32 PM Flag

    Did you create the rumor or are you just spreading it ?

  • Reply to

    IOC takeover.........

    by mvc59 Apr 22, 2015 7:52 AM
    joenobody02 joenobody02 Apr 22, 2015 9:54 AM Flag

    Totally garbage talk. What exactly is the right price for 37 trillion unhatched eggs ?

  • Reply to

    GALE 401 PR is out --- as I expected!

    by linfromchina Jun 15, 2015 7:20 AM
    joenobody02 joenobody02 Jun 15, 2015 8:03 AM Flag

    Make a list of upcoming events and post it here at the top for everyone to refer to. Stock goes up in anticipation.

  • Reply to

    How can GALE save its own life

    by joenobody02 Jun 16, 2015 11:55 AM
    joenobody02 joenobody02 Jun 16, 2015 12:41 PM Flag

    I am very aware of the shorts tactic. In fact that AVI guy was on to my other holding IOC too. It would be a shame if the shorts had managed to put GALE out of business. There are #$%$ on earth that would make a buck and the hell with everybody else.
    I did not post anything about them as I just put them on ignore all the time.
    I did not post more because I think I was reaching the words limit as the typing do not appear anymore. I even have to delete all the URLs that support my one sentence summary ( like the NASDAQ figure on institution ownership). In fact, for every sell there was 5 buys last quarter.
    Again, shareholders need to be much more vocal in poking the management if we hope to benefit from GALE's true value.

  • Reply to

    FCPA violation?

    by oliver.gump May 21, 2015 6:59 PM
    joenobody02 joenobody02 May 22, 2015 2:42 AM Flag

    If what you said is true I will back up the truck and load up on IOC. It tells me IOC finally know how to work in a third world country. Money buys everything, government and critics of government. Ever since the invention of money, bribe is the way to get things done. Ha ha ha ha !!

  • Reply to

    Request has been submitted

    by rsdmdd May 26, 2015 8:20 AM
    joenobody02 joenobody02 May 26, 2015 3:49 PM Flag

    That moron is also active in another stock I hold - GALE. Looks like he is specialised in bashing stocks with great promises but not quite there yet.

  • joenobody02 joenobody02 Jun 4, 2015 5:18 AM Flag

    The later the better.

  • Reply to

    Comes Monday, GALE wil open 1.75

    by lifeisgreat45 Jun 5, 2015 4:06 PM
    joenobody02 joenobody02 Jun 5, 2015 4:18 PM Flag

    I would love the opportunity to buy more at 1.75. Hope you are right.

  • joenobody02 by joenobody02 Jun 17, 2015 11:05 AM Flag

    I am proposing that we write a letter to the management suggesting the followings: -
    (1) To incentives the management in fending off undervalued takeover attempts . We propose the compensation structure of the management be altered to include granting them options to the tune of 5% of the company.(Void if the company is takeover,)
    (2) To fend off unfriendly takeover attempts. We propose that the management converts the potential into concrete income avenues by immediately actively seek out partnerships with international pharmaceutical companies by selling them the marketing right of their local market.

    Please voice your opinion as to the pros and cons of this letter. What should be added. IF you do not like the idea, please propose yours for all to critic.

  • Reply to

    6 bucks.......

    by reality_gerald Jun 24, 2015 3:25 PM
    joenobody02 joenobody02 Jun 24, 2015 6:04 PM Flag

    Do yourself a favor. Sell 12 $70 calls. That way you can at least get more than your $66 target. I also think you should not be getting nasty posts on your pending move. Everyones situation is different. May be you have other places that will treat your money better than IOC could, so why not. As for me, I need it to go way over 100 to even consider letting some go.

  • Reply to

    CC taking place much earlier than usual.

    by clyde_frogg May 4, 2015 8:31 AM
    joenobody02 joenobody02 May 4, 2015 9:51 AM Flag

    Strong sign ? The market does not think so. All things oily on my screen gone green except for one POS of a stock. Guess which one.
    The management may be afraid to hold the cc in June since they will have to answer questions on the lack of progress drilling.

  • Reply to

    Almost 2 blank

    by edsilverstreak May 29, 2015 10:51 AM
    joenobody02 joenobody02 May 29, 2015 12:58 PM Flag

    He is also bashing my other stock GALE which has gone up from 1.2 to 1.63 since I mentioned it a few days back. His master must be really mad at him for not doing his job.

  • I know what the long arguments are - that the lawsuit is more of a problem for Dreamwork than for GALE but I am simply trying to image the worst possible outcome and consequence. I can almost hear the short argument - that GALE will not get to be a $20 billion company. I believe it will base solely on its science and the potential market. Sorry again Jame2tx, it is not $200 billions - that was a typo in the last sentence of the source you cited nd misinterpreted. I am surprised you read it so hastily and am even more surprised at the upticks you got and the mindless cheering that followed.
    (3) The possible need for further dilution is real. I do not know if the FDA will grant GALE anything early or that Roche will attempt an early takeover. If none of these materialise ( I don't think they will ), GALE will have to go back to the market. However, by the time this happens, say in 2016, the clinical trial results would have pushed the share price substantially higher, making fund raising that much less painful to absorb. Thus, I am not worried future funding issues will stress the share price too much. You longs here when the last dilution took place really had it hard and I took advantage of the drop to come in and I don't think the next fund raising will look anything like this time.
    All of these argument things on a successful clinical trial outcome and all data from the past ( and to some extent from that of GNBC ) are supportive.

  • Reply to

    Did Wahoo spud yesterday or today??

    by warrenbuffett244 Jun 1, 2015 9:44 PM
    joenobody02 joenobody02 Jun 3, 2015 12:35 AM Flag

    It will spud tomorrow . The answer will still be the same if you ask next week or next month.

  • joenobody02 joenobody02 Jun 5, 2015 3:52 PM Flag

    You are going to jail for spreading rumours to manipulating a stock for personal gain. They love fresh meat like you in jail house.

  • Reply to

    If you are investor of GALE, read this..

    by vryprof Jun 7, 2015 1:57 PM
    joenobody02 joenobody02 Jun 7, 2015 2:27 PM Flag

    The release you cited is out of date . There informaiton is superseded by the latest information ala the ASCO abstract. The 38% reduction in recurrency was from data in which the low dosage treated patients were counted. 11/22 control and 9/29 301 treated
    If only the 1000 mcg treated patients were considered we get 11/22 control and 1/15 treated with p=0.01.
    This result was often cited on this board but really one should look at the data more critically. Obviously the lower dosage ones are not working as well as the 1000 mcg. So if we group the data differently we get
    1/15 treated with 1000 mcg recurrence
    (11+8)/(22+14) = 19/36 = 52.7% recurrence with 0-500mcg treated which is better than the 50% (11/22).
    In fact the data is even better if we assume the 100 and 500 mcg did have some effect on the patient .

AFFY
0.100.0000(0.00%)Jul 1 3:20 PMEDT